Amplification of the telomerase rna gene in human cancer

WN Keith PhD, AI Soder PhD, SF Hoare MSc, S Muire, EK Parkinson PhD

Activation of reactive oxygen generation in neutrophils of patients with non-small cell lung carcinoma

SR Craig, MA Leaver, WS Walker, PL Yap

Cytokines and soluble ICAM-1 serum levels in lung cancer

R Nano PhD, E Capelli PhD, M Civallero PhD, F Argentina PhD, C Nascimbene MD

Epidemiological methods to define lung cancer risk

U Kunze MD, R Schoberberger PhD, A Schmeiser-Rieder MD, C Dittrich MD

P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma

JE Boers MD, GPM ten Velde MD PhD, FBJM Thunnissen MD PhD

Apoptosis in non-small cell lung cancer (NSCLC): correlation with cell kinetics and prognosis

L Matturri MD, B Colombo ScD, AM Lavezzi MD

K-ras in sputum from patients with adenocarcinoma of the lung

V Somers, A Pietersen, P Theunissen MD PhD, FBJM Thunnissen MD PhD

Molecular cloning of a beta-galactoside-binding lectin, Po66-CBP, expressed in lung carcinoma

F Brichory PhD, B Desrues MD PhD, JP Le Pennec PhD, P Bourguet MD, L Dazord PhD

Type V collagen tissue content distinguishes large cell lung carcinoma from small cell, squamous, and adenocarcinoma

RL Karvonen PhD, MJ Kraut MD, CW Bedrossian MD, P Sreepathi MS, MF Dawahneh MD, F Fernandez

Differential diagnosis of thymic carcinoma and lung carcinoma with the use of antibodies to cytokeratins

I Fukai MD, A Masaoka MD PhD, T Hashimoto MD, Y Yamakawa MD, H Niwa MD, M Kiriyama MD, T Eimoto MD PhD

Dose response relationship between amphibole fibre lung burden and mesothelioma

K Rodelsperger, HJ Woitowitz, B Bruckel, R Arhelger, H Pohlabeln, KH Jockel

Diagnosis of pleural malignant mesothelioma by immunohistochemistry and electron microscopy; analysis of p53 and ki67 as prognostic indicators

V Caputo MD, F Radice MD, L Santambrogio MD, L Matturri MD

Prognostic value of e-cadherin expression in resected non-small-cell lung cancer

K Kojima, H Osada, A Mochizuki, N Yamate, H Koizumi, T Takakuwa

E-cadherin serum levels in advanced lung cancer: preliminary results

M Cioffi, AM Molinari, P Gazzerro, M Fratta, B Di Finizio, M Mosti, C Di Macchia, GA Puca

Tyrosine phosphorylation in lung cancer as a prognostic marker

K Machida MD, M Nishimura MD, M Imaizumi MD PhD, T Abe MD PhD, Y Ohnishi, K Takagi MD PhD, S Yoshii MD PhD, M Hamaguchi MD PhD

Lung cancer screening and diagnosis via k-ras mutation detection

DR Jacobson MD, JJ Xu BA, IC Smith BA

Comprehensive management of lung cancer

B Palcic PhD, S Lam MD, C MacAulay PhD, D Garner PhD

The role of taurine in interleukin-2 immunotherapy

HP Redmond FRCSI, N Finnegan BAMod, M Da Costa FRCSI, D Bouchier-Hayes FRCSI